Telangana minister launches 5 projects at Genome Valley
Real Estate

Telangana minister launches 5 projects at Genome Valley

The five projects involve a cumulative investment of Rs 11 billion
Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs.

These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector.

Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so.

Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad.

See also:
Volcan Investments, not Vedanta, to invest in semi-conductor plant
MeitY Startup Hub, Meta collaborate to accelerate XR startups


The five projects involve a cumulative investment of Rs 11 billion Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs. These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector. Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so. Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad. See also: Volcan Investments, not Vedanta, to invest in semi-conductor plantMeitY Startup Hub, Meta collaborate to accelerate XR startups

Related Stories

Gold Stories

Hi There!

Now get regular updates from CW Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Construction News on Whatsapp! Enjoy

+91 86574 75330

Join us Telegram

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back